Expression of dihydrodiol dehydrogenase and resistance to chemotherapy and radiotherapy in adenocarcinoma cells of lung

Anticancer Research

Volumn 26, Issue 4 B, 2006, Pages 2949-2955

  Hung, Jung Jyh ^a   Chow, Kuan Chih ^b   Wang, Hao Wei ^a   Wang, Liang Shun ^a,c,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c Su Ao Veterans Hospital   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Anticancer drug; Dihydrodiol dehydrogenase; Lung adenocarcinoma; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DIHYDRODIOL DEHYDROGENASE; DOXORUBICIN;

ARTICLE; CARCINOMA CELL; CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; ISOENZYMES; LUNG NEOPLASMS; OXIDOREDUCTASES; RADIATION TOLERANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33746739480     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Annual Reports of the Department of Health, the Executive Yuan, Republic of China, 2000.
2. Schiller JH, Harrington D, Belani CP et al: The Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98, 2002.
3. Pairolero PC, Williams DE, Bergstralh EJ et al: Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 38: 331-336, 1984.
4. Harpole DH Jr, Herndon JE II, Young WG Jr et al: Stage I non small cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 76: 787-796, 1995.
5. Wu CG, Hakvoort TB, Lamers WH et al: Isolation of up- and down-regulated cDNAs associated with hepatocellular carcinoma by a subtraction-enhanced display technique. Biochim Biophys Acta 1315: 169-175, 1996.
6. Velculescu VE, Zhang L, Vogelstein B et al: Serial analysis of gene expression. Science 270: 484-487, 1995.
7. Maeda S, Otsuka M, Hirata Y et al: cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. Biochem Biophys Res Commun 284: 443-449, 2001.
8. Paweletz CP, Charboneau L, Bichsel VE et al: Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20: 1981-1989, 2001.
9. Liang P, Averboukh L and Pardee AB: Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 21: 3269-3275, 1993.
10. Hsu NY, Ho HC, Chow KC et al: Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 61: 2727-2731, 2001.
11. Chen CY, Hsu CP, Hsu NY et al: Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer. Oncol Rep 9: 515-519, 2002.
12. Shou M, Harvey RG and Penning TM: Contribution of dihydrodiol dehydrogenase to the metabolism of (±)-trans-7,8-dihydroxy-7,8- dihydrobenzo[a]pyrene in fortified rat liver subcellular fractions. Carcinogenesis 13: 1575-1582, 1992.
13. Flowers-Geary L, Harvey RG and Penning TM: Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells. Chem Res Toxicol 6: 252-260, 1993.
14. Shen H, Kauvar L and Tew KD: Importance of glutathione and associated enzymes in drug response. Oncol Res 9: 295-302, 1997.
15. Ax W, Soldan M, Koch L et al: Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction. Biochem Pharmacol 59: 293-300, 2000.
16. Deng HB, Parekh HK, Chow KC et al: Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J Biol Chem 277: 15035-15043, 2002.
17. Chow KC, MacDonald TL and Ross WE: DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerae II inhibition. Mol Pharmacol 34: 467-473, 1988.
18. Hill BT, Shellard SA, Hosking LK et al: Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. Int J Radiat Oncol Biol Phys 19: 75-83, 1990.
19. Hsieh CC, Chow KC, Fahn HJ et al: Prognostic significance of HER-2/neu Overexpression in stage I adenocarcinoma of lung. Ann Thorac Surg 66: 1159-1163, 1998.
20. Chow KC and Ross WE: Topoisomerase specific drug sensitivity in relation to cell cycle progression. Mol Cell Biol 7: 3119-3123, 1987.
21. Chow KC, King CK and Ross WE: Abrogation of etoposide-mediated cytotoxicity by cycloheximide. Biochem Pharmacol 37: 1117-1122, 1988.
22. Hara A, Taniguchi H, Nakayama T et al: Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. J Biochem (Tokyo) 108: 250-254, 1990.
23. Penning TM and Sharp RB: Characterization of dihydrodiol dehydrogenase in human liver and lung. Carcinogenesis 11: 1203-1208, 1990.
24. Vogel K, Bentley P, Platt KL et al: Rat liver cytoplasmic dihydrodiol dehydrogenase. J Biol Chem 255: 9621-9625, 1980.
25. Glatt HR, Vogel K, Bentley P et al: Reduction of benzo(a)-pyrene mutagenicity by dihydrodiol dehydrogenase. Nature 277: 319-320, 1979.
26. Penning TM: Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism. Chem-Biol Interact 89: 1-34, 1993.
27. Penning TM, Ohnishi T, Ohnishi T et al: Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon frani-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem Res Toxicol 9(1): 84-92, 1996.
28. Seike K, Murata M, Hirakawa K et al: Oxidative DNA damage induced by benz[α]anthracene dihydrodiols in the presence of dihydrodiol dehydrogenase. Chem Res Toxicol 17: 1445-1451, 2004.
29. Wang LS, Chow KC, Wu YC et al: Inverse expression of dihydrodiol dehydrogenase and glutathione-s-transferase in patients with esophageal squamous cell carcinoma. Int J Cancer 111: 246-251, 2004.
30. Deng HB, Adikari M, Parekh HK et al: Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase. Cancer Chemother Pharmacol 54: 301-307, 2004.
31. Suzuki T, Fujii Y, Miyano M et al: cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase. J Biol Chem 274: 241-248, 1999.
32. Gebauer G, Mirakhur B, Nguyen Q et al: Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells. Int J Oncol 16: 321-325, 2000.
33. Cuello M, Ettenberg SA, Nau MM et al: Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells. Gynecol Oncol 81: 380-390, 2001.